Thank you to our early-career scientists for bringing your energy, fresh perspectives, and spirit of curiosity. We're grateful you're here!
Here are some moments from our recent Postdoc Summit.
#NationalPostdocAppreciationWeek
September is #LeukodystrophyAwarenessMonth.
Vanishing White Matter is a rare, progressive leukodystrophy that usually appears in early childhood. There's currently no approved treatment.
Together with our partners at @ULFUnited and the Vanishing White Matter Families Foundation, we’re working to increase awareness and understanding of the disease and support the needs of this community.
#VanishingWhiteMatter#Leukodystrophy#LeukoAware
This month marks 13 years since Calico’s start. While our mission hasn't changed – to understand the biology of aging and use what we learn to help people live longer, healthier lives – our team has grown a lot since then.
Our work now spans clinical- and early-stage programs across several aging and age-related disease areas, all of it building on the fundamental research that comes first. Thank you to our team, our collaborators, and everyone else who helped us get here.
A new method for tracking protein-protein interactions in real time in living cells could open unexplored possibilities for understanding how cellular processes change with age. (1/9)
Additional contributors include Alfred Millett-Sikking, Magdalena Preciado Lopez, Aaron Nile, Prashant Rao, Zena Jensvold, and Hannah Baddock. Lachlan Whitehead created this animation of TTM in action. (8/9)
Today, that foundation supports our progress from discovery into clinical- and early-stage programs across multiple age-related diseases.
We continue to build on our original vision, working to translate insights into potential therapies that may improve healthspan.
We recently joined the @PKDFoundation community at PKDCon, which brought together people living with ADPKD, their caregivers, and family members; and the PKD Centers of Excellence, a conference for nephrologists and investigators focused on advancing standards of care. (1/5)
Calico's ADPKD program is investigational. No treatment based on this research has been approved by the FDA or other governmental agency and its safety and effectiveness have not been established. (5/5)
#ADPKD